Human | SLEB5 | 100188798 | Systemic lupus erythematosus, susceptibility to, 5 | |
Human | SLEB4 | 404714 | systemic lupus erythematosus, susceptibility to, 4 | |
Human | NHLRC1 | 378884 | NHL repeat containing 1 | |
Human | SLC6A19 | 340024 | solute carrier family 6 (neutral amino acid transporter), member 19 | |
Human | DAOA | 267012 | D-amino acid oxidase activator | Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified The DAOA gene may play a role in predisposing individuals to a mixed phenotype of psychosis and mania and to impairments in related neuropsychological traits |
Human | ANKK1 | 255239 | ankyrin repeat and kinase domain containing 1 | It is suggested that in methamphetamine psychosis the TaqI A polymorphism of dopamine D2 receptor not only regulates prolongation of psychosis symptoms but also influences the form of the temporal lobe |
Human | SLEH1 | 170682 | systemic lupus erythematosus with hemolytic anemia 1 | |
Human | DTNBP1 | 84062 | dystrobrevin binding protein 1 | Two highly significant peaks of haplotype sharing were found: one for psychotic patients with any diagnosis at the location of dysbindin, the other peak for patients with schizophrenia on chromosome 1p36 Our genetic evidence suggests that DTNBP1 is involved in psychotic liability not only for schizophrenia but also for other psychotic disorders, including substance-induced psychosis |
Human | SLEB3 | 64695 | systemic lupus erythematosus susceptibility 3 | |
Human | BANK1 | 55024 | B-cell scaffold protein with ankyrin repeats 1 | |
Human | GNB1L | 54584 | guanine nucleotide binding protein (G protein), beta polypeptide 1-like | markers associated with psychosis are also correlated with alterations in GNB1L expression, raising the hypothesis that the risk to develop psychosis at this locus could be mediated in a dose sensitive manner via gene expression |
Human | PDE11A | 50940 | phosphodiesterase 11A | |
Human | DISC1 | 27185 | disrupted in schizophrenia 1 | Allelic heterogeneity within DISC1 leading to heterogeneity in psychotic and bipolar spectrum disorders |
Human | B3GAT1 | 27087 | beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Polymorphic or other variation of the 11q telomere may affect the activity of B3GAT1 and be a risk factor for schizophrenia and related psychoses in the general population |
Human | PTPN22 | 26191 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | |
Human | ZFYVE26 | 23503 | zinc finger, FYVE domain containing 26 | |
Human | VPS13A | 23230 | vacuolar protein sorting 13 homolog A (S. cerevisiae) | |
Human | TREX1 | 11277 | three prime repair exonuclease 1 | |
Human | NPC2 | 10577 | Niemann-Pick disease, type C2 | |
Human | HUWE1 | 10075 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | |
Human | PICK1 | 9463 | protein interacting with PRKCA 1 | findings suggest that the PICK1 gene may be implicated in the susceptibility to spontaneous relapse of methamphetamine psychosis and that, as an intracellular adapter protein, PICK1 may play a role in the pathophysiology of methamphetamine psycho |
Human | ITM2B | 9445 | integral membrane protein 2B | |
Human | AIP | 9049 | aryl hydrocarbon receptor interacting protein | |
Human | SELENBP1 | 8991 | selenium binding protein 1 | Elevated SELENBP1 is a possibly consistent feature in the schizophrenic brain and this could underlie some commonalities of psychosis across the boundaries of diagnoses |
Human | EPM2A | 7957 | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | |